Wegovy linked to rare 'eye stroke' (NAION) raising safety concerns

Analysis of FDA database and online discussions links high-dose semaglutide (Wegovy) to rare optic nerve injury causing sudden blindness. Challenges common perception of GLP-1 safety, especially in men.